Tech Company Financing Transactions

Xytis Funding Round

Sanderling Ventures and private investors participated in a $7.5 million funding round for Xytis. The round was announced on 9/30/2007.

Transaction Overview

Company Name
Announced On
9/30/2007
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors

Sanderling Ventures (Roger Flugel)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
101 Theory 100
Irvine, CA 92617
USA
Email Address
Overview
Xytis Inc. is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates.
Profile
Xytis LinkedIn Company Profile
Social Media
Xytis Company Twitter Account
Company News
Xytis News
Facebook
Xytis on Facebook
YouTube
Xytis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Vincent Simmon
  Vincent Simmon LinkedIn Profile  Vincent Simmon Twitter Account  Vincent Simmon News  Vincent Simmon on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2007: MedServe venture capital transaction
Next: 9/30/2007: Local Marketers venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary